2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (vol 290, pg 140, 2019)

被引：1

作者：

Mach, Francois ^{[1
]}

Baigent, Colin ^{[2
]}

Catapano, Alberico L. ^{[3
]}

Koskinas, Konstantinos C. ^{[4
]}

Casula, Manuela ^{[5
,6
]}

Badimon, Lina ^{[7
]}

Chapman, M. John ^{[3
,8
,9
,13
]}

De Backer, Guy G. ^{[10
]}

Delgado, Victoria ^{[11
]}

Ference, Brian A. ^{[12
]}

Graham, Ian M. ^{[13
]}

Halliday, Alison ^{[14
]}

Landmesser, Ulf ^{[15
,16
,17
]}

Mihaylova, Borislava ^{[18
,19
,20
]}

Pedersen, Terje R. ^{[21
]}

Riccardi, Gabriele ^{[22
]}

Richter, Dimitrios J. ^{[23
]}

Sabatine, Marc S. ^{[24
,25
]}

Taskinen, Marja-Riitta ^{[26
]}

Tokgozoglu, Lale ^{[27
]}

Wiklund, Olov ^{[28
]}

Nibouche, Djamaleddine ^{[29
]}

Zelveian, Parounak H. ^{[30
]}

Siostrzonek, Peter ^{[31
]}

Najafov, Ruslan ^{[32
]}

van de Borne, Philippe ^{[33
]}

Pojskic, Belma ^{[34
]}

Postadzhiyan, Arman ^{[35
]}

Kypris, Lambros ^{[36
]}

Spinar, Jindrich ^{[37
]}

Larsen, Mogens Lytken ^{[38
]}

Eldin, Hesham Salah ^{[39
]}

Viigimaa, Margus ^{[40
]}

Strandberg, Timo E. ^{[41
]}

Ferrieres, Jean ^{[42
]}

Agladze, Rusudan ^{[43
]}

Laufs, Ulrich ^{[44
]}

Rallidis, Loukianos ^{[45
]}

Bajnok, Laszlo ^{[46
]}

Gudjonsson, Thorbjorn ^{[47
]}

Maher, Vincent ^{[48
]}

Henkin, Yaakov ^{[49
]}

Gulizia, Michele Massimo ^{[50
]}

Mussagaliyeva, Aisulu ^{[1
,51
]}

Bajraktari, Gani ^{[52
]}

Kerimkulova, Alina ^{[53
]}

Latkovskis, Gustays ^{[54
]}

Hamoui, Omar ^{[55
]}

Slapikas, Rimvydas ^{[56
]}

Visser, Laurent ^{[57
]}

机构：

[1] Geneva Univ Hosp, Dept Cardiol, 4 Gabrielle Perret Gentil, CH-1211 Geneva, Switzerland

[2] Univ Oxford, Nuffield Dept Populat Hlth, Richard Doll Bldg,Roosevelt Dr, Oxford OX3 7LF, England

[3] Univ Milan, Dept Pharmacol & Biomol Sci, Multimed IRCCS, Via Balzaretti 9, I-20133 Milan, Italy

[4] Bern Univ Hosp, Cardiol, Inselspital, Bern, Switzerland

[5] Univ Milan, Dept Pharmacol & Biomol Sci DiSFeB, Epidemiol & Prevent Pharmacol Serv SEFAP, Milan, Italy

[6] IRCCS MultiMed, Milan, Italy

[7] IR Hosp Santa Creu & St Pau, Cardiovasc Program ICCC & CiberCV, Barcelona, Spain

[8] Sorbonne Univ, Natl Inst Hlth & Med Res, INSERM, Paris, France

[9] Pitie Salpetriere Univ Hosp, Div Endocrinol Metab, Paris, France

[10] Univ Ghent, Fac Med & Hlth Sci, Publ Hlth & Primary Care, Ghent, Belgium

[11] Leiden Univ, Med Ctr, Cardiol, Leiden, Netherlands

[12] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Naturally Randomized Trials, Cambridge, England

[13] Trinity Coll Dublin, Cardiol, Dublin, Ireland

[14] Univ Oxford, Nuffield Dept Surg, NIHR Oxford Biomed Res Ctr, Oxford, England

[15] Charite Univ Med Berlin, Dept Cardiol, Berlin, Germany

[16] Berlin Inst Hlth, Berlin, Germany

[17] German Ctr Cardiovasc Res DZHK, Berlin, Germany

[18] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England

[19] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England

[20] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England

[21] Oslo Univ Hosp, Prevent Cardiol, Oslo, Norway

[22] Univ Naples Federico II, Clin Med & Surg, Naples, Italy

[23] Euroclinic, Dept Cardiac, Athens, Greece

[24] Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, 75 Francis St, Boston, MA 02115 USA

[25] Harvard Med Sch, Boston, MA 02115 USA

[26] Univ Helsinki, Res Program Clin & Mol Metab, Helsinki, Finland

[27] Hacettepe Univ, Cardiol, Ankara, Turkey

[28] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden

[29] Algerian Soc Cardiol, Algiers, Algeria

[30] Armenian Cardiologists Assoc, Yerevan, Armenia

[31] Austrian Soc Cardiol, Vienna, Austria

[32] Azerbaijan Soc Cardiol, Baku, Azerbaijan

[33] Belgian Soc Cardiol, Ixelles, Belgium

[34] Assoc Cardiologists Bosnia & Herzegovina, Sarajevo, Bosnia & Herceg

[35] Bulgarian Soc Cardiol, Sofia, Bulgaria

[36] Cyprus Soc Cardiol, Strov Nicosia, Cyprus

[37] Czech Soc Cardiol, Brno, Czech Republic

[38] Danish Soc Cardiol, Copenhagen, Denmark

[39] Egyptian Soc Cardiol, Giza, Egypt

[40] Estonian Soc Cardiol, Tallinn, Estonia

[41] Finnish Cardiac Soc, Oulu, Finland

[42] French Soc Cardiol, Paris, France

[43] Georgian Soc Cardiol, Tbilisi, Georgia

[44] German Cardiac Soc, Mannheim, Germany

[45] Hellen Soc Cardiol, Athens, Greece

[46] Hungarian Soc Cardiol, Budapest, Hungary

[47] Iceland Soc Cardiol, Reykjavik, Iceland

[48] Irish Cardiac Soc, Dublin, Ireland

[49] Israel Heart Soc, Ramat Gan, Israel

[50] Italian Federat Cardiol, Florence, Italy

来源：

ATHEROSCLEROSIS | 2020年 / 294卷

关键词：

D O I：

10.1016/j.atherosclerosis.2019.12.004

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：80 / 82

页数：3

共 50 条

[31] 2018 ESC/EACTS Guidelines onmyocardial revascularization (vol 40, pg 87, 2019)
Neumann, F. J.
Sousa-Uva, M.
Ahlsson, A.
Alfonso, F.
Banning, A. P.
Benedetto, U.
Byrne, R. A.
Collet, J. P.
Falk, V
Head, S. J.
Juni, P.
Kastrati, A.
Koller, A.
Kristensen, S. D.
Niebauer, J.
Richter, D. J.
Seferovic, P. M.
Sibbing, D.
Stefanini, G. G.
Windecker, S.
Yadav, R.
Zembala, M. O.
Wijns, W.
Glineur, D.
Aboyans, V
Agewall, S.
Andreotti, F.
Barbato, E.
Baumbach, A.
Brophy, J.
Bueno, H.
Calvert, P. A.
Capodanno, D.
Davierwala, P. M.
Delgado, V
Dudek, D.
Freemantle, N.
Funck-Brentano, C.
Gaemperli, O.
Gielen, S.
Gilard, M.
Gorenek, B.
Haasenritter, J.
Haude, M.
Ibanez, B.
Iung, B.
Jeppsson, A.
Katritsis, D.
Knuuti, J.
Kolh, P.
EUROPEAN HEART JOURNAL, 2019, 40 (37) : 3096 - 3096
[32] ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes Recommendations for cardiovascular imaging
Saraste, Antti
Knuuti, Juhani
HERZ, 2020, 45 (05) : 409 - 420
[33] Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias(vol 70, pg 72 yr 2017)
Catapano, Alberico L.
Graham, Ian
De Backer, Guy
Wiklund, Olov
Chapman, M. John
Drexel, Heinz
Hoes, Arno W.
Jennings, Catriona S.
Landmesser, Ulf
Pedersen, Terje R.
Reiner, Zeljko
Riccardi, Gabriele
Taskinen, Marja-Riita
Tokozoglu, Lale
Monique Verschuren, W. M.
Vlachopoulos, Charalambos
Wood, David A.
Luis Zamorano, Jose
REVISTA ESPANOLA DE CARDIOLOGIA, 2018, 71 (06): : 509 - 510
[34] ESC-Leitlinie Dyslipidämien: die 10 KernbotschaftenKritische BewertungCritical review of the ESC Guidelines 2019 for the management of dyslipidaemias in 10 key-messages
Kai Toussaint
Claudia Brückner
MMW - Fortschritte der Medizin, 2020, 162 (10) : 45 - 48
[35] The changing landscape of lipid-lowering therapy after the new ESC/EAS guidelines for the management of dyslipidaemias: Launching the era of triple hypolipidaemic therapy in very high risk patients
Rallidis, Loukianos S.
ATHEROSCLEROSIS, 2020, 292 : 231 - 233
[36] Comments on the European Society of Cardiology (ESC) Guidelines (2019) on "Diabetes, Prediabetes and cardiovascular Diseases" (vol 41, pg 328, 2020)
Marx, N.
Frantz, S.
Gitt, A. K.
Zirlik, A.
KARDIOLOGE, 2020, 14 (06): : 492 - 493
[37] New 2013 American ACC / AHA guidelines on the treatment of plasma cholesterol to reduce atherosclerotic cardiovascular risk: comparison with the ESC / EAS recommendations for the management of dyslipidemias
Catapano, Alberico L.
Averna, Maurizio
Faggiano, Pompilio
Novo, Salvatore
GIORNALE ITALIANO DI CARDIOLOGIA, 2014, 15 (01) : 19 - 20
[38] LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments
Rizos, Christos V.
Skoumas, Ioannis
Rallidis, Loukianos
Skalidis, Emmanouil
Tziomalos, Konstantinos
Garoufi, Anastasia
Anagnostis, Panagiotis
Sfikas, George
Kotsis, Vasileios
Doumas, Michalis
Kolovou, Genovefa
Lambadiari, Vaia
Dima, Ioanna
Kiouri, Estela
Zacharis, Evangelos
Agapakis, Dimitrios
Attilakos, Achilleas
Antza, Christina
Vlachopoulos, Charalambos
Liberopoulos, Evangelos N.
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 345 : 119 - 124
[39] The impact of the 2019 ESC/EAS dyslipidaemia guidelines on real-world initial lipid-lowering therapy in patients with acute myocardial infarction
Kong, Xiangqi
He, Gang
Quan, Xiaoqing
Tan, Zhixiong
Yan, Fengjuan
Chen, Xiehui
MEDICINE, 2024, 103 (12) : E37637
[40] 2018 Guidelines for the management of dyslipidemia in Korea (vol 34, pg 723, 2019)
Rhee, E. J.
Kim, H. C.
Kim, J. H.
Lee, E. Y.
Kim, B. J.
Kim, E. M.
Song, Y.
Lim, J. H.
Kim, H. J.
Choi, S.
Moon, M. K.
Na, J. O.
Park, K. Y.
Oh, M. S.
Han, S. Y.
Noh, J.
Yi, K. H.
Lee, S. H.
Hong, S. C.
Jeong, I. K.
KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (05): : 1171 - 1171

← 1 2 3 4 5 →